Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel

Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2024-2032

The global anticoagulants market size reached US$ 41.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 90.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and application.

Drug Class Insights:

• Novel Oral Anticoagulants (NOACs)
• Heparin and Low Molecular Weight Heparin (LMWH)
• Vitamin K Antagonist
• Others

The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.

Route of Administration Insights:

• Oral Anticoagulant
• njectable Anticoagulant

A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Others

A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.

Application Insights:

• Atrial Fibrillation and Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others

A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global anticoagulants market in 2023?

2. What is the expected growth rate of the global anticoagulants market during 2024-2032?

3. What are the key factors driving the global anticoagulants market?

4. What has been the impact of COVID-19 on the global anticoagulants market?

5. What is the breakup of the global anticoagulants market based on the drug class?

6. What is the breakup of the global anticoagulants market based on the route of administration?

7. What is the breakup of the global anticoagulants market based on the distribution channel?

8. What is the breakup of the global anticoagulants market based on the application?

9. What are the key regions in the global anticoagulants market?

10. Who are the key players/companies in the global anticoagulants market?
Show more